metaPreg - Carvedilol (versus unexposed) during pregnancy

Carvedilol (versus unexposed) updated on 12-17-2024

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	39.89 [0.79, 2010.55]	-	1 study	4,054	1	not evaluable	ROB	-
Major congenital malformations	39.89 [0.79, 2010.55]	-	1 study	4,054	1	not evaluable	ROB	-
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Small for gestational age (weight)	2.36 [0.83, 6.69]	0%	2 studies	23	45	not evaluable	ROB	-
Preterm (< 37 weeks)	2.02 [0.56, 7.31]	-	1 study	22	13	not evaluable	ROB	-
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Caesarean	9.34 [3.23, 26.99]	0%	2 studies	226	45	not evaluable	ROB	18.16 [5.91; .]
Assisted deliveries (forceps, vacuum, ...)	0.63 [0.03, 11.39]	-	1 study	6	32	not evaluable	ROB	-
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Neonatal death (< 28 days of life)	7.96 [0.15, 419.18]	-	1 study		13	not evaluable	ROB	-
Hide endpoints reported in only one study ...